- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02359734
A National Study of Intravenous Medication Errors
A National Study of Intravenous Medication Errors: Understanding How to Improve Intravenous Safety With Smart Pumps
To identify the key issues around use of computerized patient infusion devices (called "smart pumps").
To develop strategies that will improve the prevention of intravenous errors that will be broadly applicable.
The investigators will conduct a national study using the general methodology developed by Husch et al. to allow a rapid assessment of the frequency and types of medication errors at an institution.
The key questions the investigators will address are:
- What are the frequency and types of intravenous medication errors?
- How much variability is there by frequency and type among settings?
- After review of the initial data, what strategies appear to have the greatest potential for reducing intravenous medication error frequency?
- How effective is an intervention including a bundle of these strategies at multiple sites?
Study Overview
Status
Conditions
Detailed Description
Overall Study Design: This is a multi-hospital study to investigate medication errors using smart pumps. The proposed study will be conducted over three phases for a total of 36 months phases. In Year 1, an observational study will be conducted by investigators at ten multiple hospital sites. The investigators will prospectively compare the medication, dose, and infusion rate on the IV pump with the prescribed medication, doses, and rate in the medical record. Preventability with smart pump technology will be retrospectively determined based on a rigorous definition of currently available technology. The investigators will also make comparisons across sites by overall rate and degree of variability among sites.
Then, in Year 2, these results will be evaluated, and a consensus process including a face-to-face meeting will take place to evaluate the types of events and to develop an intervention which will be implemented at multiple sites. After a run-in period, the intervention will be tested in Year 3 at the sites, and the data will be analyzed, and the investigators will produce a report and a set of recommendations.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02120
- Brigham and Women's Hospital
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients if they receive any IV fluid or medication on the day of observation in the study units.
Exclusion Criteria:
- patients who are under 21 years old.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
Brigham and Women's Hospital.
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Brigham and Women's Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Johns Hopkins University Hospital
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Johns Hopkins University Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Winchester Medical Center
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Winchester Medical Center.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Central DuPage Hospital
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Central DuPage Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Vanderbilt University
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Vanderbilt University Medical Center.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Massachusetts General Hospital
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Massachusetts General Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
University of California, San Diego
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at University of California, San Diego.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Maricopa Integrated Health System
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Maricopa Integrated Health System.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Danbury Hospital
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Danbury Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
Candler Hospital
Patients who had IV medications with smart pumps in one surgical unit, one medical unit, one Medical ICU, and one surgical ICU at Candler Hospital.
In these unit, the intervention bundle was implemented.
|
Smart pump safety intervention bundle includes three components--1) eliminating unauthorized medications; implement standardized discontinuation policy of medications, implement standardized keep vein open rates and keep vein open rate order sets, and implement standardized verbal order practice.
2) Implement standardized intravenous(IV) labeling and IV tubing labels.
3) Implement standardized drug library lists and drug library use policies
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Incident rates of wrong dose
Time Frame: Two years
|
The same medication but the dose is different from the prescribed order.
|
Two years
|
Incident rates of wrong rate
Time Frame: Two years
|
A different rate is displayed on the pump from that prescribed in the medical record.
Also refers to weight based doses calculated incorrectly including using a wrong weight.
|
Two years
|
Incident rates of wrong concentration
Time Frame: Two years
|
An amount of a medication in a unit of solution that is different from the prescribed order.
|
Two years
|
Incident rates of wrong IV fluids/medications
Time Frame: Two years
|
A different fluid/medication as documented on the IV bag label is being infused compared with the order in the medical record.
|
Two years
|
Incident rates of delay of medication administration
Time Frame: Two years
|
An order to start or change medication or rate not carried out within 4 hours of the written order or intended start time per institution policy.
|
Two years
|
Incident rates of omission of IV fluids/medications
Time Frame: Two years
|
The medication ordered was not administered to a patient or administered anytime after 4 hours of the intended start time.
|
Two years
|
Incident rates of unauthorized medication
Time Frame: Two years
|
Fluids/medications are administered to the patient but no order is present in medical record.
This includes failure to document a verbal order.
|
Two years
|
Incident rates of patient identification (ID) error (wrong patient)
Time Frame: Two years
|
Patient either has no ID band on or information on the ID band or label is incorrect.
|
Two years
|
Incident rates of smart pump or drug library not used
Time Frame: Two years
|
Smart pump is not used (bypassing smart pump) or smart pump was used but the drug library was not selected, rather manual entry mode was used (bypassing drug library)
|
Two years
|
Incident rates of oversight allergy
Time Frame: Two years
|
Medication is administered to a patient with a known allergy to the drug or class.
|
Two years
|
Incident rates of pump setting error
Time Frame: Two years
|
Setting programmed into the pump is different from the prescribed order.
|
Two years
|
Compliance rate of label not complete according to policy
Time Frame: Two years
|
Documented information on the medication label is different from required information per institution policy.
|
Two years
|
Compliance rate of IV tubing not tagged according to policy
Time Frame: Two years
|
IV tubing change label is not tagged per institution policy.
|
Two years
|
Incident rates of expired drug
Time Frame: Two years
|
The expiration date or time of the fluids/medications has passed.
|
Two years
|
Overall medication errors
Time Frame: Two years
|
Total number of all observed medication errors(including outcome 1-14)
|
Two years
|
Higher-severity medication errors
Time Frame: Two years
|
All medication errors with an NCC MERP severity rating of C or greater (excluding violation of hospital policy errors;outcome 12 and 13).
|
Two years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Compliance rate of using smart pump use
Time Frame: Two years
|
Compliance rate of using smart pump
|
Two years
|
Compliance rate of using drug library use
Time Frame: Two years
|
Compliance rate of using drug library
|
Two years
|
Potential adverse drug events
Time Frame: Two years
|
Medication errors with potential for harm categorized as D (errors that would have required increased monitoring to preclude harm) or higher by NCC MERP Index
|
Two years
|
Collaborators and Investigators
Sponsor
Collaborators
Publications and helpful links
General Publications
- Schnock KO, Dykes PC, Albert J, Ariosto D, Call R, Cameron C, Carroll DL, Drucker AG, Fang L, Garcia-Palm CA, Husch MM, Maddox RR, McDonald N, McGuire J, Rafie S, Robertson E, Saine D, Sawyer MD, Smith LP, Stinger KD, Vanderveen TW, Wade E, Yoon CS, Lipsitz S, Bates DW. The frequency of intravenous medication administration errors related to smart infusion pumps: a multihospital observational study. BMJ Qual Saf. 2017 Feb;26(2):131-140. doi: 10.1136/bmjqs-2015-004465. Epub 2016 Feb 23.
- Schnock KO, Dykes PC, Albert J, Ariosto D, Cameron C, Carroll DL, Donahue M, Drucker AG, Duncan R, Fang L, Husch M, McDonald N, Maddox RR, McGuire J, Rafie S, Robertson E, Sawyer M, Wade E, Yoon CS, Lipsitz S, Bates DW. A Multi-hospital Before-After Observational Study Using a Point-Prevalence Approach with an Infusion Safety Intervention Bundle to Reduce Intravenous Medication Administration Errors. Drug Saf. 2018 Jun;41(6):591-602. doi: 10.1007/s40264-018-0637-3.
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
- 2012P000709
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Medication Administered in Error
-
Hackensack Meridian HealthOmnicellCompletedMedication Compliance | Medication Administered in ErrorUnited States
-
NYU Langone HealthRecruitingMedication Administered in ErrorUnited States
-
Assistance Publique - Hôpitaux de ParisMinistry of Health, FranceCompletedMedication Administered in ErrorFrance
-
University of Southern DenmarkEnrolling by invitationMedication Administered in ErrorDenmark
-
National Healthcare Group, SingaporeCompletedMedication Adherence | Medication Administered in Error
-
Assistance Publique - Hôpitaux de ParisWithdrawnMedication Administered in Error
-
Brigham and Women's HospitalNational Institute on Aging (NIA); Ideas42CompletedMedication Administered in Error | Antipsychotics and Neuroleptics ToxicityUnited States
-
University of Colorado, DenverAgency for Healthcare Research and Quality (AHRQ)RecruitingChild, Only | Medication Compliance | Medication Administered in Error | Disabilities Multiple | Medication InteractionUnited States
-
Western University, CanadaCentre for Addiction and Mental Health; London Health Sciences Centre; Texas... and other collaboratorsCompletedNurse's Role | Simulation of Physical Illness | Medication Administered in ErrorCanada
-
Anglia Ruskin UniversityUniversity of Manchester; Pharmacy Research UK; Ashford and St. Peter's Hospitals...Not yet recruitingMedication Administered in Error | Medication Adverse Effects | Medication Reaction